Cite
HARVARD Citation
Wang, D. et al. (2019). Statistical considerations in a delayed‐start design to demonstrate disease modification effect in neurodegenerative disorders. Pharmaceutical statistics. pp. 407-419. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wang, D. et al. (2019). Statistical considerations in a delayed‐start design to demonstrate disease modification effect in neurodegenerative disorders. Pharmaceutical statistics. pp. 407-419. [Online].